Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-471-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 = 500 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 500 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In the key study, the acute oral toxicity of the test item was assessed according to OECD guideline 423.
The starting dose was selected on the basis of the available information about the test item. The LD50 value > 200 – 2000 mg/kg bw according to safety data sheet.
The acute toxic class method was carried out involving a stepwise procedure with the use of 300 mg/kg bw as the starting dose in three female rats. No animals died in first step, so further three female rats were treated with the same dose. No animals died in second step, too, so further three female rats were treated with higher (2000 mg/kg bw) dose. All animals died in third step.
Animals were weighed, observed for lethality and toxic symptoms for 14 days after the treatment. Gross pathological examination was carried out in animals died on Day 1, as well as 15th day after the treatment in survivor animals.
No death occurred at 300 mg/kg bw single oral dose of the test item. All female rats in step 1 and step 2 survived until the end of the 14-day observation period. All rats dosed at 2000 mg/kg bw died on Day 1.
In first step, no clinical symptoms were observed on the day of the treatment and during the 14-day observation period, the general state and behaviour of experimental animals were normal.
In second step, no clinical symptoms were observed on the day of the treatment and during the 14-day observation period, the general state and behaviour of experimental animals were normal.
In third step, CNS - and emotion symptoms (decreased activity, closed eyes, tremor, vocalisation), disturbance of coordination (abnormal gait), decreased righting reflex, decreased muscular - body - tone and a disturbances of the autonomic functions (diarrhea, piloerection) were observed in animals between treatment day (from second hours) and Day 1.
The body weight development was undisturbed in all surviving animals.
All animals treated with 300 mg/kg bw dose survived until the scheduled autopsy on Day 15. All organs of the animals treated with 300 mg/kg bw proved to be free of treatment related gross pathological changes.
All animals treated with 2000 mg/kg bw dose died spontaneously during the study and were necropsied on Day 1. External (anus contaminated with faeces, blood around the nose) and internal necropsy findings (stomach and intestines were full of discharge, blushed mucous membrane in the stomach, haemorrhages on the cardia, sanguine intestinal wall) found in animals of group 3 were connected with test item toxic effect.
The estimated LD50 value is 500 mg/kg bw on basis of LD50 cut off mg/kg bw, because three animals died in 2000 mg/kg bw at third step.
An older study was available on the acute oral toxicity of the test item in the Sprague-Dawley strain rat following OECD guideline 401 (1981). No data on the composition of the test material used in the study is available. Following a range-finding study, a group of 10 fasted animals (5/sex) was given a single oral dose of test item, as a suspension in arachis oil at a dose level of 200 mg/kg bw. The animals were observed for 14 days after the day of dosing and were then killed for gross pathological examination.
All animals showed expected gain in bodyweight during the study, there were no deaths, no signs of systemic toxicity were noted and no abnormalities were noted during the necropsy. The acute oral median lethal dose (LD50) of the test item in the Sprague-Dawley strain rat was found to be greater than 200 mg/kg bw but less than 2000 mg/kg bw.
Justification for classification or non-classification
Based on an acute oral LD50 value of 500 mg/kg bw in rat, the test item is classified for acute toxicity in category 4 (H302: Harmful if swallowed) within the CLP Regulation (EC 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.